Pharmacological agents for NASH

被引:0
|
作者
Vlad Ratziu
机构
[1] Hôpital Pitié Salpêtrière,Department of Hepatology and Gastroenterology
来源
Nature Reviews Gastroenterology & Hepatology | 2013年 / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Optimal management of NASH is required because the condition can progress to cirrhosis and end-stage liver failure. Once first-line therapy with diet and lifestyle changes has failed, pharmacological intervention is indicated. This Review discusses the available evidence from clinical trials on pharmacological agents for NASH.
引用
收藏
页码:676 / 685
页数:9
相关论文
共 50 条
  • [1] Pharmacological agents for NASH
    Ratziu, Vlad
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (11) : 676 - 685
  • [2] PHARMACOLOGICAL TARGETS FOR NASH
    Martinez, C.
    Luz, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 : 24 - 24
  • [3] Pharmacological treatment of NASH
    Serfaty, Lawrence
    PRESSE MEDICALE, 2019, 48 (12): : 1489 - 1495
  • [4] NASH: A glance at the landscape of pharmacological treatment
    Brodosi, Lucia
    Marchignoli, Francesca
    Petroni, Maria Letizia
    Marchesini, Giulio
    ANNALS OF HEPATOLOGY, 2016, 15 (05) : 673 - 681
  • [5] PREVENTION AND PHARMACOLOGICAL INTERVENTIONS IN NAFLD/NASH
    De Block, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A13 - A13
  • [6] Current and future pharmacological therapies for NAFLD/NASH
    Sumida, Yoshio
    Yoneda, Masashi
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (03) : 362 - 376
  • [7] Current and future pharmacological therapies for NAFLD/NASH
    Yoshio Sumida
    Masashi Yoneda
    Journal of Gastroenterology, 2018, 53 : 362 - 376
  • [8] Nash SocialWelfare Approximation for Strategic Agents
    Branzei, Simina
    Gkatzelis, Vasilis
    Mehta, Ruta
    EC'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON ECONOMICS AND COMPUTATION, 2017, : 611 - 628
  • [9] PHARMACOLOGICAL AGENTS AND AUSCULTATION
    DELEON, AC
    HARVEY, WP
    MODERN CONCEPTS OF CARDIOVASCULAR DISEASE, 1975, 44 (05) : 23 - 28
  • [10] Azapeptides as pharmacological agents
    Zega, A
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (05) : 589 - 597